Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#167 most reported symptom for this vaccine
Injection site inflammation has been reported 92 times in association with Pneumococcal (Prevnar) vaccination in VAERS. This represents 0.3% of all 27,970 reports for this vaccine.
Among these reports, 7 mentioned death (7.61%) and 5 involved hospitalization (5.4%).
Injection site inflammation is the #167 most frequently reported symptom for Pneumococcal (Prevnar) out of 1407 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 92 reports of Injection site inflammation after Pneumococcal (Prevnar) vaccination may seem alarming, but context is critical.
The 7.61% mortality rate among these reports is elevated, but this reflects the severity of the condition itself rather than vaccine causation.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.